White & Case Advised Ayyan Investment Company On Sale Of Subsidiaries Through Share Swap With Dallah Healthcare

White & Case Advised Ayyan Investment Company On Sale Of Subsidiaries Through Share Swap With Dallah Healthcare

White & Case LLP advised Ayyan Investment Company (Ayyan) on the sale of all its shares in two subsidiaries Al-Ahsa Medical Company and Al-Salam Medical Company in exchange for newly issued shares in Dallah Healthcare Company (Dallah). Post-transaction, Ayyan will hold 3.83% of Dallah’s share capital following the capital increase.

The deal involved a share swap arrangement with a cash consideration component, marking the first Saudi public M&A transaction structured as a ‘significant transaction’ under the Rules on the Offer of Securities and Continuing Obligations involving a share swap between two listed companies.

“Advising Ayyan on this first-of-its-kind transaction showcases White & Case’s ability to accommodate the complex nature of the evolving Saudi public M&A deal market and to ensure our clients achieve their goals,” said Sami Al-Louzi, Partner at White & Case, who led the transaction.

The White & Case team was led by Sami E. Al-Louzi (Partner, Dubai), with support from Khalid Al-Gublan, Husam Azhar, Abdulrahman Al-Khudairy (Associates, Riyadh), and Hamzeh Al Rasheed (Associate, Dubai).

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.